In September, Fresenius Medical Care AG experienced an 8.6% decrease in short interest, while their stock rose to $20.04.

Fresenius Medical Care AG (FMS) experienced an 8.6% drop in short interest in September, totaling 683,300 shares. The stock rose to $20.04 by September 30. The company reported earnings per share of $0.38 for the last quarter, in line with estimates, while revenue was $5.13 billion, below expectations. Analysts have mixed views on FMS, with an average rating of "Hold" and a target price of $23. The firm specializes in dialysis services for renal disease patients.

October 18, 2024
3 Articles